Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 10:15 AM ET | Feedback | Site Changes | Help
The Company is a global developer, manufacturer and marketer of vitro diagnostic products for the over-the-counter pregnancy and fertility/ovulation test market and the professional rapid diagnostic test markets.
View Ticker Page (IMA)
Results 1 - 10 of 30 : 123
Recs
Sangfarmer (< 20) Submitted: 2/28/08 12:19 PM : Start Price: $30.17 IMA Score: 1.45
This firm has been unnecessarily punished as a "serial acquirer" that does not fully recognize its potential. As efficiencies are realized and new products are fully developed, this company will begin to see bottom line results which will reverse th...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
CaptainTBone (65.61) Submitted: 5/10/08 6:58 AM : Start Price: $34.56 IMA Score: -6.30
The negatives have already been factored in and tehn some. With the Matria acquisition complete, you will begin to see the benefits of lower expenses and higher margins. The average age of the American population is growing due to seniors living lo...
hleggett (45.29) Submitted: 2/26/08 4:15 PM : Start Price: $32.97 IMA Score: 4.17
Adown to half former value, it's going lower. Management cannot explain why it's paying $900 million for a $475 million company, Matria. Yep, it's a stinker until the CEO can explain this deal. Obviously, the shareholders aren't buying the sorry g...
roblester (54.82) Submitted: 8/28/06 11:16 PM : Start Price: $32.65 IMA Score: -7.25
Refinanced and ready to go.
mozaictheory (< 20) Submitted: 11/04/07 8:45 PM : Start Price: $62.52 IMA Score: 29.12
No deal is better than a bad deal. Grossly overpaid for Biosite. Debt load and lack of earnings will ultimately end this honeymoon.
bigmoneybastard (< 20) Submitted: 7/21/07 3:06 PM : Start Price: $50.35 IMA Score: -19.03
good risk-reward ratio, should outperform
ironringer (38.22) Submitted: 3/27/08 9:08 AM : Start Price: $29.25 IMA Score: 2.32
bottomed out?
boater9384 (< 20) Submitted: 4/02/08 11:50 PM : Start Price: $31.02 IMA Score: -0.90
There is a lot that points to this going up. Just check the numbers, the growth, the R&D expenditures, the debt/asset ratio, everything.
digiho (50.90) Submitted: 2/03/07 10:18 AM : Start Price: $42.75 IMA Score: -15.54
overpriced from cash flow point of view.negative cash flow. growing revenues by acquisitions but eventually will have problems due to low cash flow
davet999 (< 20) Submitted: 5/10/08 8:29 AM : Start Price: $34.56 IMA Score: -6.30
IMA has acquired some very strong IP in the emerging cardiac diagnostic markets.
Terms & Conditions
RSS Headlines
Fool UK